Vaccine and pharma formulations maker with a growing nutrition/baby-care line; exports to 50+ countries.
Price
Market Cap
Sector
Healthcare
Rank
| Line item | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 | FY26 |
|---|---|---|---|---|---|---|---|---|
| LiabilitiesEquity Capital | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 |
| Reserves | 193 | -235 | 871 | 837 | 836 | 829 | 820 | 829 |
| Borrowings | 742 | 820 | 34 | 20 | 21 | 22 | 23 | 24 |
| Other Liabilities | 449 | 587 | 848 | 407 | 378 | 433 | 405 | 404 |
| Total Liabilities | 1.4k | 1.2k | 1.8k | 1.3k | 1.2k | 1.3k | 1.3k | 1.3k |
| AssetsFixed Assets | 657 | 609 | 622 | 600 | 582 | 567 | 594 | 620 |
| CWIP | 24 | 34 | 17 | 42 | 102 | 128 | 110 | 100 |
| Investments | 6 | 0 | 5 | 13 | 40 | 3 | 3 | 10 |
| Other Assets | 703 | 534 | 1.1k | 615 | 517 | 592 | 547 | 532 |
| Total Assets | 1.4k | 1.2k | 1.8k | 1.3k | 1.2k | 1.3k | 1.3k | 1.3k |
| Line item | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|
| ActivitiesCash from Operating | 105 | -30 | 107 | -108 | -422 | 0 | -27 | 17 |
| Cash from Investing | -6 | -35 | -48 | 1.3k | 430 | 10 | 65 | -40 |
| Cash from Financing | -101 | 91 | -47 | -1.2k | -18 | -3 | -3 | -1 |
| SummaryCapital Expenditure | — | — | — | — | — | — | — | — |
| Free Cash Flow | 100 | -21 | 89 | -119 | -424 | -71 | -77 | -37 |
| FCF Margin | — | — | — | — | — | — | — | — |
This looks cyclical, and we don't have enough quarters to establish a through-cycle earnings base. Valuing it off the current point in the cycle would be misleading.
PANACEABIO · CYCLICAL_UNMODELABLE
Guides on how to read this kind of business and the numbers that matter.